These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 10607707)
1. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Vukmanovic-Stejic M; Vyas B; Gorak-Stolinska P; Noble A; Kemeny DM Blood; 2000 Jan; 95(1):231-40. PubMed ID: 10607707 [TBL] [Abstract][Full Text] [Related]
2. Functional characterization and modulation of cytokine production by CD8+ T cells from human immunodeficiency virus-infected individuals. Maggi E; Manetti R; Annunziato F; Cosmi L; Giudizi MG; Biagiotti R; Galli G; Zuccati G; Romagnani S Blood; 1997 May; 89(10):3672-81. PubMed ID: 9160672 [TBL] [Abstract][Full Text] [Related]
3. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816 [TBL] [Abstract][Full Text] [Related]
4. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses. Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity. Sad S; Krishnan L; Bleackley RC; Kägi D; Hengartner H; Mosmann TR Eur J Immunol; 1997 Apr; 27(4):914-22. PubMed ID: 9130644 [TBL] [Abstract][Full Text] [Related]
6. In vitro generation of allospecific human CD8+ T cells of Tc1 and Tc2 phenotype. Halverson DC; Schwartz GN; Carter C; Gress RE; Fowler DH Blood; 1997 Sep; 90(5):2089-96. PubMed ID: 9292548 [TBL] [Abstract][Full Text] [Related]
7. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells. Vinay DS; Kwon BS Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348 [TBL] [Abstract][Full Text] [Related]
8. Effector cell-derived lymphotoxin alpha and Fas ligand, but not perforin, promote Tc1 and Tc2 effector cell-mediated tumor therapy in established pulmonary metastases. Dobrzanski MJ; Reome JB; Hollenbaugh JA; Hylind JC; Dutton RW Cancer Res; 2004 Jan; 64(1):406-14. PubMed ID: 14729652 [TBL] [Abstract][Full Text] [Related]
9. CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. Li L; Sad S; Kägi D; Mosmann TR J Immunol; 1997 May; 158(9):4152-61. PubMed ID: 9126975 [TBL] [Abstract][Full Text] [Related]
10. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection. Dobrzanski MJ; Reome JB; Dutton RW J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679 [TBL] [Abstract][Full Text] [Related]
11. The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors. Helmich BK; Dutton RW J Immunol; 2001 Jun; 166(11):6500-8. PubMed ID: 11359800 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. Gerosa F; Paganin C; Peritt D; Paiola F; Scupoli MT; Aste-Amezaga M; Frank I; Trinchieri G J Exp Med; 1996 Jun; 183(6):2559-69. PubMed ID: 8676077 [TBL] [Abstract][Full Text] [Related]
13. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383 [TBL] [Abstract][Full Text] [Related]
14. CD8(+) T cells with distinct cytokine-producing features and low cytotoxic activity in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps. Ma J; Shi LL; Deng YK; Wang H; Cao PP; Long XB; Zhang XH; Liu Y; Zeng M; Liu Z Clin Exp Allergy; 2016 Sep; 46(9):1162-75. PubMed ID: 27176491 [TBL] [Abstract][Full Text] [Related]
15. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. Sad S; Mosmann TR J Exp Med; 1995 Nov; 182(5):1505-15. PubMed ID: 7595220 [TBL] [Abstract][Full Text] [Related]
16. Type 1 Cytotoxic T Cells Increase in Placenta after Intrauterine Inflammation. Liu J; Liu Y; Panda S; Liu A; Lei J; Burd I Front Immunol; 2021; 12():718563. PubMed ID: 34566975 [TBL] [Abstract][Full Text] [Related]
17. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells. Williams NS; Engelhard VH J Immunol; 1997 Sep; 159(5):2091-9. PubMed ID: 9278294 [TBL] [Abstract][Full Text] [Related]
18. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Fowler DH; Gress RE Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730 [TBL] [Abstract][Full Text] [Related]
19. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. Cerwenka A; Carter LL; Reome JB; Swain SL; Dutton RW J Immunol; 1998 Jul; 161(1):97-105. PubMed ID: 9647212 [TBL] [Abstract][Full Text] [Related]
20. Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease. Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir MS; Feki M; Hamzaoui K Mediators Inflamm; 2004 Aug; 13(4):247-53. PubMed ID: 15545055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]